(Q36569014)

15 August 2017

1 reference

title

Autologous tumor rejection in humans: trimming the myths (English)

1 reference

15 August 2017

3

Francesco M Marincola

1 reference

15 August 2017

Ena Wang

1

1 reference

15 August 2017

Monica Panelli

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2006

1 reference

Immunological Investigations

15 August 2017

published in

1 reference

15 August 2017

volume

35

1 reference

15 August 2017

issue

3-4

1 reference

15 August 2017

page(s)

437-458

1 reference

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Definition of an optimal cytotoxic T lymphocyte epitope in the latently expressed Kaposi's sarcoma-associated herpesvirus kaposin protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Skewed maturation of memory HIV-specific CD8 T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

CD8 T Cell Clonal Expansion and Development of Effector Function Require Prolonged Exposure to Antigen, Costimulation, and Signal 3 Cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

The three Es of cancer immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Kaposi's sarcoma pathogenesis: a link between immunology and tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Is cancer dangerous to the immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Treatment of Epstein-Barr virus-associated malignancies with specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Phenotypic and functional separation of memory and effector human CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Complete regression of posttransplant lymphoproliferative disease using partially HLA-matched Epstein Barr virus-specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Adoptive cellular immunotherapy for EBV lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

The cost-effectiveness of human papillomavirus screening for cervical cancer. A review of recent modelling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Gene polymorphisms, inflammatory diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Molecular and functional profiling of memory CD8 T cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Enhancement of antitumor immunity by CTLA-4 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Genetic instabilities in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

A modified human ELISPOT assay to detect specific responses to primary tumor cell targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

A balanced review of the status T cell-based therapy against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

HLA associations in the antitumor response against malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Tumors as elusive targets of T-cell-based active immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Cytogenetic characterization of two colon cell lines by using conventional G-banding, comparative genomic hybridization, and whole chromosome painting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

T cell avidity and tumor recognition: implications and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Functional heterogeneity of vaccine-induced CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Active-specific immunization against melanoma: is the problem at the receiving end?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Quiescent phenotype of tumor-specific CD8+ T cells following immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

CD8(+) T-cell immunity to cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Polarized monocyte response to cytokine stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Immune response in cervical dysplasia induced by human papillomavirus: the influence of human immunodeficiency virus-1 co-infection -- review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Status of activation of circulating vaccine-elicited CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Immune surveillance against a solid tumor fails because of immunological ignorance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

New paths in human cancer serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Dendritic cells as vectors for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Forecasting the cytokine storm following systemic interleukin (IL)-2 administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Intensity of the vaccine-elicited immune response determines tumor clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Ex vivo analysis of tumor antigen specific CD8+ T cell responses using MHC/peptide tetramers in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Cancer vaccines based on the identification of genes encoding cancer regression antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Ex vivo identification, isolation and analysis of tumor-cytolytic T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Rational peptide-based tumour vaccine development and T cell monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Progress and controversies in developing cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

CD8+, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Peptide vaccine trials for melanoma: preclinical background and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Immunoregulatory T cells in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

T-cell clonotypes in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide-HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Posttransplant malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Melanoma-restricted genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Lineage relationship and protective immunity of memory CD8 T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Adoptive T cell therapy: Addressing challenges in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

An innate sense of danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08820130600762385

10.1080/08820130600762385

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference